e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension
Catherine E. Simpson, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Rubina M. Khair, Takahiro Sato, Khalil Bourji, Ryan J. Tedford, Stefan L. Zimmerman, Paul M. Hassoun
Source:
Eur Respir J, 53 (4) 1802067; 10.1183/13993003.02067-2018
Journal Issue:
April
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Catherine E. Simpson, Rachel L. Damico, Todd M. Kolb, Stephen C. Mathai, Rubina M. Khair, Takahiro Sato, Khalil Bourji, Ryan J. Tedford, Stefan L. Zimmerman, Paul M. Hassoun. Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension. Eur Respir J, 53 (4) 1802067; 10.1183/13993003.02067-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Towards prognostic biomarkers in pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 799-801
Year: 2012
Right ventricular function is a strong prognostic predictor of mortality in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Prognostic value of changes in radionuclide right ventricular ejection fraction in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Echocardiography: diagnostic and prognostic value in the assessment of pulmonary embolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=144
Year: 2004
Novel biomarkers for risk stratification in pulmonary arterial hypertension
Source: ERJ Open Res 2015; 1: 00008-2015
Year: 2015
Ventricular mass index correlates with pulmonary haemodynamics in patients with systemic sclerosis and suspected pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension
Source: Eur Respir J, 56 (3) 2000513; 10.1183/13993003.00513-2020
Year: 2020
Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Can right ventricle imaging improve risk stratification in pulmonary arterial hypertension?
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021
Change in right atrial minimal volume is a prognostic marker in pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
Right ventricular systolic pressure as a prognostic factor for pulmonary hypertension with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Noninvasive cardiac output measurements in patients with pulmonary hypertension
Source: Eur Respir J 2013; 42: 125-133
Year: 2013
MRI-derived regional pulmonary perfusion and cardiac function for monitoring patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy
Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment
Year: 2015
Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism
Source: Eur Respir J 2013; 42: 681-688
Year: 2013
Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005
Cardiac bioimpedance as a non-invasive tool in patients with pulmonary hypertension
Source: Annual Congress 2011 - Innovative methods in exercise testing
Year: 2011
Echocardiographic imaging in pulmonary hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018
Diagnostic accuracy of right ventricular trabecular mass measurements as measured on cardiac MRI in suspected pulmonary hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
The value of tools to assess pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 222-235
Year: 2011
Prognostic relevance of right atrial function in pulmonary arterial hypertension
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept